Pfizer signals progress on obesity pill, boosting stock

Pfizer’s stock gained ground early Thursday after the drug company said it has taken a step forward in developing a once-daily pill for obesity.

Previous post Jobless claims fall to lowest level since late May
Next post Vista Outdoor again urges shareholders to vote for sale of ammunition business to CSG